Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity Statement

v3.20.1
Condensed Consolidated Statements of Stockholders' Equity Statement - USD ($)
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Noncontrolling Interest
Beginning balance (shares) at Dec. 31, 2018   24,824,746      
Beginning balance at Dec. 31, 2018 $ 28,037,774 $ 24,825 $ 56,427,928 $ (28,670,095) $ 255,116
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options (shares)   10,000      
Exercise of stock options 12,000 $ 10 11,990    
Stock issuance costs (611)   (611)    
Stock based compensation expense 38,035   38,035    
Net income (loss) (3,280,077)     (3,280,077)  
Net loss 125,746       125,746
Net income (loss) (3,405,823)        
Ending balance (shares) at Mar. 31, 2019   24,834,746      
Ending balance at Mar. 31, 2019 24,681,375 $ 24,835 56,477,342 (31,950,172) 129,370
Beginning balance (shares) at Dec. 31, 2019   24,849,261      
Beginning balance at Dec. 31, 2019 23,353,277 $ 24,849 56,622,285 (33,379,114) 85,257
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options (shares)   1,000      
Exercise of stock options 1,200 $ 1 1,199    
Stock issuance costs (401)   (401)    
Stock based compensation expense 42,236   42,236    
Distributions to Noncontrolling interests (23,070)       (23,070)
Net income (loss) (1,202,387)     (1,202,387)  
Net loss (11,808)       (11,808)
Net income (loss) (1,190,579)        
Ending balance (shares) at Mar. 31, 2020   24,850,261      
Ending balance at Mar. 31, 2020 $ 22,182,663 $ 24,850 $ 56,665,319 $ (34,581,501) $ 73,995